Individualization of Levodopa Therapy
- 1 September 1974
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 58 (5) , 1071-1081
- https://doi.org/10.1016/s0025-7125(16)32103-4
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Effect of amantadine on L-2-14C-dopa metabolism in parkinsonismLife Sciences, 1973
- LITHIUM AND LEVODOPA IN PARKINSONISMThe Lancet, 1973
- TREATMENT OF SIDE-EFFECTS OF LEVODOPAThe Lancet, 1973
- Antiparkinsonian Drugs Pharmacological and Therapeutic AspectsDrugs, 1972
- Phentolamine Inhibition of Human Growth Hormone Secretion Induced by L-DopaHormone and Metabolic Research, 1972
- Adjuvants to L-dopa for Parkinsonism.BMJ, 1970
- MYDRIATIC RESPONSES TO SYMPATHOMIMETIC AMINES IN PATIENTS TREATED WITH L-DOPAThe Lancet, 1969
- URINE TEST FOR L-DOPA CONSUMPTIONThe Lancet, 1969
- MYDRIATIC RESPONSES TO SYMPATHOMIMETIC AMINES IN PATIENTS TREATED WITH L-DOPAThe Lancet, 1969
- EXTRAPIGMENTARY EFFECTS OF MELANOCYTE-STIMULATING HORMONE IN AMENORRHŒIC WOMENThe Lancet, 1968